Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EXACT Therapeutics AS ( (DE:56F) ) has provided an announcement.
EXACT Therapeutics AS has launched a new long-term incentive program involving share options, which will replace the current incentive program. This initiative aims to align the interests of participants, including primary insiders, with the company’s performance, potentially impacting its operational dynamics and stakeholder engagement.
More about EXACT Therapeutics AS
EXACT Therapeutics AS is a clinical-stage precision medicine company that leverages ultrasound and microbubbles for targeted drug delivery, particularly in oncology. Its Acoustic Cluster Therapy (ACT®) is designed to enhance the effectiveness of therapeutic agents across various indications, including chemotherapy, immunotherapy, and brain diseases.
YTD Price Performance: -46.81%
Average Trading Volume: 46,170
Current Market Cap: NOK126.5M
For detailed information about 56F stock, go to TipRanks’ Stock Analysis page.